ArticleArchives of medical science : AMS2012
Risk factor reduction in progression of angiographic coronary artery disease.
Article in Archives of medical science : AMS, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 15 citations in OpenAlex.
- Drug Therapy of Dyslipidemia in the Elderly.Drugs & aging · 2019Review
- Sexual health of male cardiac patients - present status and expectations of patients with coronary heart disease.Archives of medical science : AMS · 2017Article
- Correlation research between osteoporosis and left ventricular hypertrophy in older men.Archives of medical science : AMS · 2016Article
- Association of chest pain versus dyspnea as presenting symptom for coronary angiography with demographics, coronary anatomy, and 2-year mortality.Archives of medical science : AMS · 2016Article
- Observational
- Comprehensive assessment of coronary fractional flow reserve.Archives of medical science : AMS · 2015Article
- Lipid-lowering therapy in older persons.Archives of medical science : AMS · 2015Article
- ST-segment changes in high-resolution body surface potential maps measured during exercise to assess myocardial ischemia: a pilot study.Archives of medical science : AMS · 2014Article
- The Prevalence of Risk Factors of Coronary Artery Disease in the Patients who Underwent Coronary Artery Bypass Graft, Shiraz, Iran: Suggesting a Model.International cardiovascular research journal · 2014Article
- Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.Archives of medical science : AMS · 2014Article
- Exercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients.Archives of medical science : AMS · 2014Article
- Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.Archives of medical science : AMS · 2013Article
- Examination of serum pregnancy-associated plasma protein A clinical value in acute coronary syndrome prediction and monitoring.Archives of medical science : AMS · 2013Article
- Blood pressure j-curve: current concepts.Current hypertension reports · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTo investigate differences between outpatients with progressive and nonprogressive coronary artery disease (CAD) measured by coronary angiography. MATERIAL AND
methodsChart reviews were performed in patients in an outpatient cardiology practice having ≥ 2 coronary angiographies ≥ 1 year apart. Progressive CAD was defined as 1) new non-obstructive or obstructive CAD in a previously disease-free vessel; or 2) new obstruction in a previously non-obstructive vessel. Coronary risk factors, comorbidities, cardiovascular events, medication use, serum low-density lipoprotein cholesterol (LDL-C), and blood pressure were used for analysis.
resultsThe study included 183 patients, mean age 71 years. Mean follow-up duration was 11 years. Mean follow-up between coronary angiographies was 58 months. Of 183 patients, 108 (59%) had progressive CAD, and 75 (41%) had nonprogressive CAD. The use of statins, β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and aspirin was not significantly different in patient with progressive CAD or nonprogressive CAD Mean arterial pressure was higher in patients with progressive CAD than in patients with nonprogressive CAD (97±13 mm Hg vs. 92±12 mm Hg) (p<0.05). Serum LDL-C was insignificantly higher in patients with progressive CAD (94±40 mg/dl) than in patients with nonprogressive CAD (81±34 mg/dl) (p=0.09).
conclusionsOur data suggest that in addition to using appropriate medical therapy, control of blood pressure and serum LDL-C level may reduce progression of CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.